Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Regulatory Trackers
R&D
Agency Leadership
Compliance
Complete Response Letters
Drug Review Profiles
Scrip
Zydus Cadila Explores Orphan Drug Indication For NASH Candidate
Expects 20-25 New Product Launches In FY21
Feb 06 2020
•
By
Vibha Ravi
Cadila Explores More Indications For Its NASH Candidate • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip